Stan Berenshteyn
Stock Analyst at Wells Fargo
(0.32)
# 4,232
Out of 4,478 analysts
282
Total ratings
49%
Success rate
-6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintained: Buy | $55 | $45.24 | +21.57% | 54 | Jul 2, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $1 → $1.75 | $2.29 | -23.58% | 25 | Jun 26, 2026 | |
| HNGE Hinge Health | Rated: Buy | $80 → $90 | $88.52 | +1.67% | 5 | Jun 24, 2026 | |
| AMWL American Well | Rated: Buy | $12 → $9 | $9.29 | -3.12% | 13 | Jun 17, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $320 | $192.01 | +66.66% | 39 | Jun 10, 2026 | |
| DOCS Doximity | Maintained: Hold | $18 | $22.86 | -21.26% | 32 | Jun 10, 2026 | |
| HQY HealthEquity | Rated: Buy | $125 | $96.57 | +29.44% | 55 | Jun 5, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $3.5 | $3.08 | +13.64% | 35 | Jun 2, 2026 | |
| PHR Phreesia | Reiterated: Hold | $9 | $11.10 | -18.92% | 6 | May 28, 2026 | |
| OMDA Omada Health | Maintained: Hold | $17 → $18 | $22.85 | -21.23% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $9.29 | -35.41% | 8 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $30 → $22 | $33.16 | -33.66% | 3 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $23.91 | +50.56% | 2 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $15.09 | n/a | 1 | Oct 6, 2015 |
Omnicell
Jul 2, 2026
Maintained: Buy
Price Target: $55
Current: $45.24
Upside: +21.57%
Health Catalyst
Jun 26, 2026
Maintained: Hold
Price Target: $1 → $1.75
Current: $2.29
Upside: -23.58%
Hinge Health
Jun 24, 2026
Rated: Buy
Price Target: $80 → $90
Current: $88.52
Upside: +1.67%
American Well
Jun 17, 2026
Rated: Buy
Price Target: $12 → $9
Current: $9.29
Upside: -3.12%
Veeva Systems
Jun 10, 2026
Maintained: Buy
Price Target: $320
Current: $192.01
Upside: +66.66%
Doximity
Jun 10, 2026
Maintained: Hold
Price Target: $18
Current: $22.86
Upside: -21.26%
HealthEquity
Jun 5, 2026
Rated: Buy
Price Target: $125
Current: $96.57
Upside: +29.44%
GoodRx Holdings
Jun 2, 2026
Maintained: Buy
Price Target: $3.5
Current: $3.08
Upside: +13.64%
Phreesia
May 28, 2026
Reiterated: Hold
Price Target: $9
Current: $11.10
Upside: -18.92%
Omada Health
May 8, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $22.85
Upside: -21.23%
Apr 30, 2026
Maintained: Hold
Price Target: $6
Current: $9.29
Upside: -35.41%
Mar 19, 2026
Rated: Hold
Price Target: $30 → $22
Current: $33.16
Upside: -33.66%
Feb 19, 2026
Reiterated: Buy
Price Target: $41 → $36
Current: $23.91
Upside: +50.56%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $15.09
Upside: n/a